Difficulty: Medium
Average Score: 76%
Practice
A 71-year-old man with gradual impairment in short-term memory and speech is thought to have Alzheimer's disease. His primary care physician begins him on rivastigmine. This agent will most likely cause which of the following effects?
Correct answer
C
Rationale
Rivastigmine is a cholinesterase inhibitor commonly used in Alzheimer's disease to slow the breakdown of acetylcholine, a neurotransmitter crucial for memory and cognitive function. The correct answer is C) Reduced rate of loss of cognitive function.
This drug works by enhancing cholinergic transmission in the brain, which can help improve cognitive function, memory, and ability to perform daily activities in patients with Alzheimer's disease. By preventing the breakdown of acetylcholine, rivastigmine can help slow down the progression of cognitive decline in these patients.
The other options are incorrect because:
A) Improved long-term memory capability: Rivastigmine primarily helps in preserving and improving cognitive function rather than specifically enhancing long-term memory.
B) Improved speech and language function: While some cognitive functions may improve with rivastigmine, it does not directly target speech and language functions.
D) Tremors similar to that seen with parkinsonism: Rivastigmine can sometimes cause gastrointestinal side effects or mild neurological symptoms, but it is not known to cause tremors similar to those seen in parkinsonism.
Understanding the mechanism of action of CNS stimulants like rivastigmine is crucial in pharmacology to make informed decisions in patient care, especially in conditions like Alzheimer's disease where cognitive decline is a significant concern. It is important for healthcare professionals to be knowledgeable about the effects and side effects of drugs to ensure safe and effective treatment for their patients.
This drug works by enhancing cholinergic transmission in the brain, which can help improve cognitive function, memory, and ability to perform daily activities in patients with Alzheimer's disease. By preventing the breakdown of acetylcholine, rivastigmine can help slow down the progression of cognitive decline in these patients.
The other options are incorrect because:
A) Improved long-term memory capability: Rivastigmine primarily helps in preserving and improving cognitive function rather than specifically enhancing long-term memory.
B) Improved speech and language function: While some cognitive functions may improve with rivastigmine, it does not directly target speech and language functions.
D) Tremors similar to that seen with parkinsonism: Rivastigmine can sometimes cause gastrointestinal side effects or mild neurological symptoms, but it is not known to cause tremors similar to those seen in parkinsonism.
Understanding the mechanism of action of CNS stimulants like rivastigmine is crucial in pharmacology to make informed decisions in patient care, especially in conditions like Alzheimer's disease where cognitive decline is a significant concern. It is important for healthcare professionals to be knowledgeable about the effects and side effects of drugs to ensure safe and effective treatment for their patients.